1056
J. Gris et al. / Tetrahedron Letters 49 (2008) 1053–1056
compound employed by the NCI.12 Nevertheless, it did not
reach the lower toxicity level to perform in vivo studies.
(methanol): kmax nm: 270, 285; Anal. Calcd for C10H10N2O: C, 68.95;
H, 5.78; N, 16.08; found: C, 68,86; H, 5.97; N, 16.30. 3-[3-Quinoxalin-
2(1H)-one] propanoic acid (entry 3, 3c): white crystals (ethanol);
spectra data agree again with those reported by Rodrigo.14 2-[3-
Quinozalin-2(1H)-one] acetic acid (entry 4, 3d): white crystals (etha-
nol); 1H NMR (DMSO-d6): d 2.39 (s, 2H, CH2), 7.82 (m, 2H,
aromatics), 7.48 (t, 1H, aromatics), 7.69 (d, 1H, aromatics), 12.4 (s,
1H, COOH); IR (cmÀ1): 166, 1608, 3167–3435; Anal. Calcd for
C10H8N2O3: C, 58.82; H, 3,95; N, 13,72; found: C, 58.91; H, 4.09; N,
13.88. 3-Benzylquinoxalin-2(1H)-one (entry 5, 3e): white needles
(ethanol); spectra data was previously reported by us5 and agree
again with the results obtained in this work. 3-Hydroxyquinoxalin-
2(1H)-one (entry 6, 3f): white powder (ethanol) in part volatile
without decomposition, reported by Motylevski.15 3-Methyl-
benzo[g]quinoxalin-2(1H)-one (entry 7, 4a): yellow crystals (methanol/
water) reported by Rodrigo.16 3-Ethylbenzo[g]quinoxalin-2(1H)-one
(entry 8, 4b): yellow crystals (methanol/water); 1H NMR (DMSO-d6):
d 1.45 (t, 3H, CH3), 3,04 (q, 2H, CH2), 7.63 (t, 1H, aromatics), 7.69
(t, 1H, aromatics), 7.72 (t, 1H, aromatics), 7.82 (s, 1H, aromatics),
8.11 (d, 1H, aromatics), 8.23 (d, 1H, aromatics), 8.54 (s, 1H,
aromatics), 12.47 (s, 1H, NH); IR (cmÀ1): 1640, 1670, 3405; UV
(methanol): kmax nm: 272, 282; Anal. Calcd for C14H12N2O: C, 74,98;
H, 5.39; N, 12.49; found: C, 75.05; H, 5,46, N, 12,60. 3-{3-
Benzo[g]quinoxalin-2(1H)-one} propanoic acid (entry 9, 4c): yellow
crystals (methanol/water) synthesized by Rodrigo.16 There was
agreement with spectroscopic data determined in this work.
11. Typical procedure for microwave irradiation: Reactions were per-
formed in the absence of solvent. In every case equimolecular
amounts of both reactants (2 mmol) were mixed and subjected to
microwave irradiation under the reaction conditions described in
Table 1 for each compound. After the completion of the reaction
(TLC), the mixture was diluted with MeOH, EtOH or CH2Cl2 (20 ml)
and concentrated under reduced pressure to give always a solid
substance. Compounds already known were crystallized from the
appropriate solvent. Melting points were compared with those
reported in the literature, and their structure was confirmed by IR
and 1H NMR spectroscopy.
Acknowledgment
We are grateful for the financial support from Univer-
sidad de Buenos Aires (UBACyT B-087 and B-016).
References and notes
1. Kleim, J. P.; Bender, R.; Kirsch, R.; Meichsner, C.; Paessens, A.;
Ro¨sner, M.; Rubsamen Waigmann, H.; Kaiser, R.; Wichers, M.;
¨
Schneweis, K. E.; Winkler, I.; Riess, G. Antimicrob. Agents Chemo-
ther. 1995, 39, 2253.
2. Balzarini, J.; Karlsson, A.; Meichsner, C.; Pessens, A.; Riess, G.; De
Clerq, E.; Kleim, J. P. J. Virol. 1994, 68, 1986.
3. Hinsberg, H. Ann. Chem. 1887, 237, 368.
´
4. Abasolo, M. I.; Gaozza, C. H.; Fernandez, B. M. J. Heterocycl.
Chem. 1987, 24, 1771.
5. Rodrigo, G. A.; Robinshon, A. E.; Hedrera, M. E.; Kogan, M.;
´
Sicardi, S. M.; Fernandez, B. M. Trends Heterocycl. Chem. 2002, 8,
137.
6. Sukanta, K.; Biehl, E. R. Heterocycles 2006, 68, 1931.
7. Didier, V.; Benoit, M. Synth. Comunn. 1995, 25, 2319.
´
8. Baez, M. V.; Robinsohn, A.; Legaspi, M.; Hedrera, M.; Fernandez, B.
M. J. Planar Chromatogr. 2003, 16, 28.
9. Typical procedure for the biocatalytic method (compounds 1–9):
Saccharose (10% P/V in distilled water) and Saccharomyces cereviciae
(10 g) were mixed in a 1-l flask and stirred for 1 h at room
temperature. Then, 100 mg of accurately measured (1 mmol) ortho-
phenylenediamine or 2,3-diaminonaphthalene, and different a-keto-
acids in excess (1.4 mmol) were added to the mixture. Stirring was
continued for 48 h at room temperature. After the reaction was
completed, the mixture was centrifuged and the acid pellet was
isolated and re-suspended in methanol. This mixture was stirred for
another 24 h and centrifuged. The upper layer was separated and the
solvent, evaporated. The solid obtained was washed to eliminate the
saccharose residue and render the final heterocyclic compound.
Products were crystallized from the appropriate solvent. Melting
points were compared with those reported in the literature, and their
structure was confirmed by IR and 1H NMR spectroscopy.
12. Pharmacological assays were made by the National Cancer Institute
(NCI, USA). Patent: Rodrigo, Gabriela A.; Ferna´ndez Beatriz M.
‘Cromo´foros tric´ıclicos dinitrogenados precursores de drogas anti-
HIV y compuestos farmace´uticos que las contienen’. INPI No. AR
030103167 (presented August 2004). Accepted April 2007.
13. Nishio, T. J. Org. Chem. 1984, 49, 827.
10. Spectra data for products: 3-Methylquinoxalin-2(1H)-one (entry 1,
3a): white needles (anhydrous ethanol); spectral properties agree with
those described by Nishio.13 3-Ethylquinoxalin-2(1H)-one (entry 2,
3b): white crystals (ethanol); 1H NMR (DMSO-d6): d 1.50 (t, 3H,
CH3), 3.06 (q, 2H, CH2), 7.60 (t, 1H, aromatics), 7.69 (t, 1H,
aromatics), 12.50 (s, 1H, NH); IR: (cmÀ1), 1640, 1670, 3405; UV
14. Rodrigo, G. A.; Piton, K. B.; Bekerman, D. G.; Abasolo, M.;
Ferna´ndez, B. M. Inf. Technol. 1999, 10, 29.
15. Motylevski, Z. Bull Intern. Acad. Sci. Cracovie. 1908, 32–34; Ber.
1908, 41, 800.
16. Rodrigo, G.; Bekerman, D.; Renou, S.; Abasolo, M.; Ferna´ndez, B.
M. J. Heterocycl. Chem. 1997, 34, 505.